Biomedical Implications of Heavy Metals Induced Imbalances in Redox Systems

Several workers have extensively worked out the metal induced toxicity and have reported the toxic and carcinogenic effects of metals in human and animals. It is well known that these metals play a crucial role in facilitating normal biological functions of cells as well. One of the major mechanisms associated with heavy metal toxicity has been attributed to generation of reactive oxygen and nitrogen species, which develops imbalance between the prooxidant elements and the antioxidants (reducing elements) in the body. In this process, a shift to the former is termed as oxidative stress. The oxidative stress mediated toxicity of heavy metals involves damage primarily to liver (hepatotoxicity), central nervous system (neurotoxicity), DNA (genotoxicity), and kidney (nephrotoxicity) in animals and humans. Heavy metals are reported to impact signaling cascade and associated factors leading to apoptosis. The present review illustrates an account of the current knowledge about the effects of heavy metals (mainly arsenic, lead, mercury, and cadmium) induced oxidative stress as well as the possible remedies of metal(s) toxicity through natural/synthetic antioxidants, which may render their effects by reducing the concentration of toxic metal(s). This paper primarily concerns the clinicopathological and biomedical implications of heavy metals induced oxidative stress and their toxicity management in mammals.

[1]  P. Auinger,et al.  Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. , 2000, Public health reports.

[2]  R. Guy,et al.  Metals and the skin. , 1993, Critical reviews in toxicology.

[3]  K. Chia,et al.  Delta-aminolevulinic acid dehydratase (ALAD) polymorphism and susceptibility of workers exposed to inorganic lead and its effects on neurobehavioral functions. , 2004, Neurotoxicology.

[4]  K. Jan,et al.  NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. , 2000, Circulation research.

[5]  M. Arnush,et al.  Cadmium-induced damage to primary cultures of rat Leydig cells. , 2003, Reproductive toxicology.

[6]  A. Flegal,et al.  Stable isotopic tracers of lead mobilized by DMSA chelation in low lead-exposed rats. , 1992, Toxicology and applied pharmacology.

[7]  Xianglin Shi,et al.  Carcinogenic metals and NF‐κB activation , 2001, Molecular and Cellular Biochemistry.

[8]  K. Chaudhuri,et al.  Role of arginine, a component of aqueous garlic extract, in remediation of sodium arsenite induced toxicity in A375 cells , 2014 .

[9]  L. Müller Protective effects of DL-α-lipoic acid on cadmium-induced deterioration of rat hepatocytes , 1989 .

[10]  V. Srinivasan,et al.  Melatonin, immune function and aging , 2005, Immunity & Ageing.

[11]  S. Pavlović,et al.  Protective influence of vitamin E on antioxidant defense system in the blood of rats treated with cadmium. , 2003, Physiological research.

[12]  F R Gibb,et al.  Pulmonary retention of lead: an experimental study in man. , 1980, Environmental research.

[13]  J. Cerbón-Solórzano,et al.  Vitamin-E reduces the oxidative damage on delta-aminolevulinic dehydratase induced by lead intoxication in rat erythrocytes. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  J. Chisolm,et al.  Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children. , 1985, The Journal of pharmacology and experimental therapeutics.

[15]  Frans J Kok,et al.  Mercury, fish oils, and the risk of myocardial infarction. , 2002, The New England journal of medicine.

[16]  M. Cronin,et al.  Metals, toxicity and oxidative stress. , 2005, Current medicinal chemistry.

[17]  M. Kondoh,et al.  Cadmium induces apoptosis partly via caspase-9 activation in HL-60 cells. , 2002, Toxicology.

[18]  S. Flora,et al.  Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats , 2007, Cell Biology and Toxicology.

[19]  Michael C Henson,et al.  Endocrine Disruption by Cadmium, a Common Environmental Toxicant with Paradoxical Effects on Reproduction , 2004, Experimental biology and medicine.

[20]  M. Nordberg General aspects of cadmium: transport, uptake and metabolism by the kidney. , 1984, Environmental health perspectives.

[21]  B. Suarez,et al.  Type I (insulin dependent) diabetes mellitus , 1981, Diabetologia.

[22]  S. Leonard,et al.  Cadmium inhibits the electron transfer chain and induces reactive oxygen species. , 2004, Free radical biology & medicine.

[23]  J. Malchaire,et al.  Surveillance of workers exposed to mercury vapour:validation of a previously proposed biological threshold limit value for mercury concentration in urine. , 1985, American journal of industrial medicine.

[24]  A. M. del Batlle,et al.  Bilirubin is highly effective in preventing in vivo delta-aminolevulinic acid-induced oxidative cell damage. , 2003, Biochimica et biophysica acta.

[25]  R. Goyer,et al.  Lead toxicity: current concerns. , 1993, Environmental health perspectives.

[26]  G Nistico,et al.  Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. , 1995, Life sciences.

[27]  J. Woodside,et al.  Antioxidants in health and disease , 2001, Journal of clinical pathology.

[28]  H. Gilbert,et al.  Protein disulfide isomerase. , 1998, Methods in enzymology.

[29]  C. Hernández-Luna,et al.  Mechanisms of the toxic effect of lead. I. Free lead in erythrocyte. , 1993, Journal of exposure analysis and environmental epidemiology.

[30]  R. Reiter,et al.  Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: amelioration by melatonin , 2004, Cell Biology and Toxicology.

[31]  A. Bode,et al.  Transactivation of AP-1 in AP-1-luciferase reporter transgenic mice by arsenite and arsenate. , 2001, Anticancer Research.

[32]  P. R. Yallapragada,et al.  Lead-induced increase in antioxidant enzymes and lipid peroxidation products in developing rat brain , 2008, BioMetals.

[33]  A. Angerio,et al.  The Cellular Effect of Lead Poisoning and Its Clinical Picture , 2008 .

[34]  Xianglin Shi,et al.  Metal-induced oxidative stress and signal transduction. , 2004, Free radical biology & medicine.

[35]  A. Florea,et al.  Occurrence, use and potential toxic effects of metals and metal compounds , 2006, Biometals.

[36]  K. Shanmugasundaram,et al.  Oxidative stress and the development of diabetic complications ‐ antioxidants and lipid peroxidation in erythrocytes and cell membrane. , 1995, Cell biology international.

[37]  A. Bernard,et al.  The influence of orally-administered vitamin C or zinc on the absorption of and the biological response to lead. , 1983, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[38]  B. Zondek,et al.  Inactivation of Estrone by Liver After Exclusion of Reticuloendothelial System.∗ , 1941 .

[39]  I. Antolín,et al.  Melatonin increases gene expression for antioxidant enzymes in rat brain cortex , 1998, Journal of pineal research.

[40]  P. Goering,et al.  Mercury induces regional and cell-specific stress protein expression in rat kidney. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  P. Qiu,et al.  Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation. , 2014, Cancer letters.

[42]  K. Safranow,et al.  Inhibition of erythrocyte phosphoribosyltransferases (APRT and HPRT) by Pb2+: a potential mechanism of lead toxicity. , 2009, Toxicology.

[43]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .

[44]  C Cox,et al.  Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. , 1987, The Journal of pharmacology and experimental therapeutics.

[45]  G. M. Kannan,et al.  Therapeutic Efficacy of a Few Diesters of Meso 2,3‐Dimercaptosuccinic Acid during Sub‐Chronic Arsenic Intoxication in Rats , 1997 .

[46]  S. Flora Influence of Simultaneous Supplementation of Zinc and Copper During Chelation of Lead in Rats , 1991, Human & experimental toxicology.

[47]  T. Aiuchi,et al.  Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+‐dependent production of superoxide , 2001, International journal of cancer.

[48]  F. Marcheselli,et al.  Melatonin: a peroxyl radical scavenger more effective than vitamin E. , 1994, Life sciences.

[49]  Xianglin Shi,et al.  Oxidative mechanism of arsenic toxicity and carcinogenesis , 2004, Molecular and Cellular Biochemistry.

[50]  L. Packer,et al.  Alpha-lipoic acid in liver metabolism and disease. , 1998, Free radical biology & medicine.

[51]  R. Vijayaraghavan,et al.  Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats. , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[52]  Wilfred W. Li,et al.  The tumor promoter arsenite stimulates AP‐1 activity by inhibiting a JNK phosphatase. , 1996, The EMBO journal.

[53]  R. Reiter,et al.  The Oxidant/Antioxidant Network: Role of Melatonin , 1999, Neurosignals.

[54]  Y. Ikeda,et al.  Glutathione reductase is expressed at high levels in pancreatic islet cells , 2004, Redox report : communications in free radical research.

[55]  S. Stice Speciation, Metabolism, Toxicity, and Protein-binding of Different Arsenic Species in Human Cells , 2014 .

[56]  P. Tchounwou,et al.  Mercury-Induced Externalization of Phosphatidylserine and Caspase 3 Activation in Human Liver Carcinoma (HepG2) Cells , 2006, International Journal of Environmental Research and Public Health.

[57]  E. Kenyon,et al.  A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. , 2001, Toxicology.

[58]  Rosalee S. Hellberg,et al.  Risk-Benefit Analysis of Seafood Consumption: A Review , 2012 .

[59]  H. Kolb,et al.  Type 1 (insulin-dependent) diabetes mellitus and nitric oxide , 1992, Diabetologia.

[60]  T. Lyons Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes? , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[61]  Lisa H. Mason,et al.  Pb Neurotoxicity: Neuropsychological Effects of Lead Toxicity , 2014, BioMed research international.

[62]  Robert Edwards,et al.  Glutathione Transferases , 2010, The arabidopsis book.

[63]  J. Pi,et al.  A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. , 2003, Free radical biology & medicine.

[64]  T. Clarkson,et al.  The Toxicology of Mercury and Its Chemical Compounds , 2006, Critical reviews in toxicology.

[65]  Yang Zhao,et al.  Association Between δ-Aminolevulinic Acid Dehydratase (ALAD) Polymorphism and Blood Lead Levels: A Meta-regression Analysis , 2007 .

[66]  M. Yousef,et al.  Cadmium-induced changes in lipid peroxidation, blood hematology, biochemical parameters and semen quality of male rats: protective role of vitamin E and beta-carotene. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[67]  R. Reiter,et al.  Protection against oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants. , 2003, Biochimica et biophysica acta.

[68]  Paul B Tchounwou,et al.  Neurotoxic Effects and Biomarkers of Lead Exposure: A Review , 2009, Reviews on environmental health.

[69]  A. Smith,et al.  Cancer risks from arsenic in drinking water. , 1992, Environmental health perspectives.

[70]  W F Fitzgerald,et al.  Mercury and monomethylmercury: present and future concerns. , 1991, Environmental health perspectives.

[71]  D. Averbeck,et al.  Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). , 2006, Biochimie.

[72]  S. Shima,et al.  Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead , 1985, International archives of occupational and environmental health.

[73]  N. Kamiloğlu,et al.  Role of dietary vitamin E in cadmium-induced oxidative damage in rabbit's blood, liver and kidneys. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[74]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[75]  F. Morel,et al.  Biochemistry: A cadmium enzyme from a marine diatom , 2005, Nature.

[76]  B. Bravenboer,et al.  The role of oxidative stress in neuropathy and other diabetic complications. , 1995, Diabetes/metabolism reviews.

[77]  Ashish Mehta,et al.  Heavy metal induced oxidative stress & its possible reversal by chelation therapy. , 2008, The Indian journal of medical research.

[78]  B. Halliwell,et al.  alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. , 1999, Free radical biology & medicine.

[79]  R. Goyer,et al.  Pathological effects of lead. , 1973, International review of experimental pathology.

[80]  R. Tsien,et al.  Inhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase* , 2000, The Journal of Biological Chemistry.

[81]  J. Ward,et al.  Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. , 2004, Toxicology.

[82]  Y. Li,et al.  An Investigation of Outpatient Children's Blood Lead Level in Wuhan China , 2014, PloS one.

[83]  L H Li,et al.  Psychological effects of low exposure to mercury vapor: application of a computer-administered neurobehavioral evaluation system. , 1993, Environmental research.

[84]  A. Santra,et al.  Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. , 2007, Toxicology and applied pharmacology.

[85]  B. Hultberg,et al.  Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. , 2001, Toxicology.

[86]  Kathleen Shordt,et al.  Arsenic in drinking water. , 2001, Journal of environmental health.

[87]  D W Barfuss,et al.  Mechanisms of action of 2,3-dimercaptopropane-1-sulfonate and the transport, disposition, and toxicity of inorganic mercury in isolated perfused segments of rabbit proximal tubules. , 1998, Molecular pharmacology.

[88]  A. Holmgren,et al.  Thioredoxin and glutaredoxin systems. , 2019, The Journal of biological chemistry.

[89]  Chaitali Sarkar,et al.  ADDITIVE BENEFICIAL EFFECT OF FOLIC ACID AND VITAMIN B12 CO-ADMINISTRATION ON ARSENIC-INDUCED OXIDATIVE DAMAGE IN CARDIAC TISSUE IN VIVO , 2013 .

[90]  H. Aposhian,et al.  BAL increases the arsenic-74 content of rabbit brain. , 1983, Toxicology and applied pharmacology.

[91]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[92]  T. Nyokong,et al.  The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: An adsorptive voltammetric study , 1998, Journal of pineal research.

[93]  L. Herzenberg,et al.  High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[94]  J. Salonen,et al.  Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. , 1995, Circulation.

[95]  J. Nyengaard,et al.  Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.

[96]  S. Tandon,et al.  Preventive effect of vitamin E in cadmium intoxication. , 1992, Biomedical and environmental sciences : BES.

[97]  D Quig,et al.  Cysteine metabolism and metal toxicity. , 1998, Alternative medicine review : a journal of clinical therapeutic.

[98]  Robert L. Jones,et al.  Trends in Blood Lead Levels and Blood Lead Testing Among US Children Aged 1 to 5 Years, 1988–2004 , 2009, Pediatrics.

[99]  M. Filipič,et al.  Molecular mechanisms of cadmium induced mutagenicity , 2006, Human & experimental toxicology.

[100]  S. Kety,et al.  THE TREATMENT OF LEAD POISONING BY SODIUM CITRATE , 1943 .

[101]  R. Reiter,et al.  Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin , 2002, Mechanisms of Ageing and Development.

[102]  A. Ranjbar,et al.  The Role of Oxidative Stress in Metals Toxicity; Mitochondrial Dysfunction as a Key Player , 2014, Galen Medical Journal.

[103]  S. Koul,et al.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors. , 2013, Genes & cancer.

[104]  P. Bijur,et al.  Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children. , 1996, Environmental health perspectives.

[105]  N. Oku,et al.  DNA-strand breaks induced by dimethylarsinic acid, a metabolite of inorganic arsenics, are strongly enhanced by superoxide anion radicals. , 1995, Biological & pharmaceutical bulletin.

[106]  K. Sawicka-Kapusta,et al.  Histopathological changes in the liver, kidneys, and testes of bank voles environmentally exposed to heavy metal emissions from the steelworks and zinc smelter in Poland. , 2004, Environmental research.

[107]  R. Kostrzewa,et al.  Effect of prenatal lead exposure on nigrostriatal neurotransmission and hydroxyl radical formation in rat neostriatum: dopaminergic-nitrergic interaction. , 2008, Toxicology.

[108]  O Andersen,et al.  Principles and recent developments in chelation treatment of metal intoxication. , 1999, Chemical reviews.

[109]  W. Waissmann,et al.  Occupational exposure and effects on the male reproductive system. , 2006, Cadernos de saude publica.

[110]  B. H. Choi,et al.  Oxidative stress in neurotoxic effects of methylmercury poisoning. , 1996, Neurotoxicology.

[111]  D. Breljak,et al.  Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs , 2010, BioMetals.

[112]  M. Oset-Gasque,et al.  Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. , 2006, Free radical biology & medicine.

[113]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[114]  A. Parrish,et al.  Metal-induced apoptosis: mechanisms. , 2003, Mutation research.

[115]  D. Rusyniak,et al.  Heavy metal poisoning: clinical presentations and pathophysiology. , 2006, Clinics in laboratory medicine.

[116]  B. Adegbesan,et al.  Effect of lead exposure on liver lipid peroxidative and antioxidant defense systems of protein-undernourished rats , 2007, Biological Trace Element Research.

[117]  B. Nehru,et al.  N-acetylcysteine exposure on lead-induced lipid peroxidative damage and oxidative defense system in brain regions of rats , 2004, Biological Trace Element Research.

[118]  M. Waalkes,et al.  Strain difference of cadmium accumulation by liver slices of inbred Wistar-Imamichi and Fischer 344 rats. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[119]  R. Marcos,et al.  In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay. , 2004, Mutagenesis.

[120]  A. Bode,et al.  The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. , 2002, Critical reviews in oncology/hematology.

[121]  S. Okada,et al.  Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. , 2001, Biochemical and biophysical research communications.

[122]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[123]  Minoru Yoshida,et al.  Behavioral changes in metallothionein-null mice after the cessation of long-term, low-level exposure to mercury vapor. , 2006, Toxicology letters.

[124]  Liying Wang,et al.  Arsenic‐induced NFκβ transactivation through Erks‐ and JNKs‐dependent pathways in mouse epidermal JB6 cells , 2001, Molecular and Cellular Biochemistry.

[125]  Kentaro Yamada,et al.  Poly(ADP-ribose) synthesis induced by nitric oxide in a mouse β-cell line , 1995 .

[126]  S. Banni,et al.  Adipose tissue: Another target organ for lead accumulation? A study on sardinian children (Italy) , 2013, American journal of human biology : the official journal of the Human Biology Council.

[127]  W. Stewart,et al.  Relation of alleles of the sodium-potassium adenosine triphosphatase alpha 2 gene with blood pressure and lead exposure. , 2001, American journal of epidemiology.

[128]  R. Reiter Melatonin: clinical relevance. , 2003, Best practice & research. Clinical endocrinology & metabolism.

[129]  I. Lancranjan,et al.  Reproductive ability of workmen occupationally exposed to lead. , 1975, Archives of environmental health.

[130]  B. Halliwell,et al.  Relationships between plasma measures of oxidative stress and metabolic control in NIDDM , 1997, Diabetologia.

[131]  P. Landrigan,et al.  Neurobehavioural effects of developmental toxicity , 2014, The Lancet Neurology.

[132]  T. Lyons,et al.  Lipoprotein glycation and its metabolic consequences. , 1997, Diabetes.

[133]  T. Masuhara [Toxicity of mercury]. , 1975, Nihon Shika Ishikai zasshi.

[134]  K. Hurlbut,et al.  DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. , 1998, The Journal of pharmacology and experimental therapeutics.

[135]  J. Schulz,et al.  Metabolic and Toxic Encephalopathies , 2003 .

[136]  R. Sumathi,et al.  Effect of DL α-lipoic acid on tissue redox state in acute cadmium-challenged tissues , 1996 .

[137]  P. Ghezzi,et al.  Glutathionylation pathways in drug response. , 2007, Current opinion in pharmacology.

[138]  J. Rooney The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. , 2007, Toxicology.

[139]  A. Othman,et al.  Role of melatonin in ameliorating lead induced haematotoxicity. , 2004, Pharmacological research.

[140]  S. Flora,et al.  Chelation in Metal Intoxication , 2010, International journal of environmental research and public health.

[141]  J. S. Woods,et al.  Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. , 1993, Biochemical pharmacology.

[142]  A. Porter,et al.  Signal transduction pathways regulated by arsenate and arsenite , 1999, Oncogene.

[143]  S. Flora,et al.  Quercetin Administration During Chelation Therapy Protects Arsenic-Induced Oxidative Stress in Mice , 2008, Biological Trace Element Research.

[144]  Elisabeth Heseltine,et al.  Meeting of the IARC working group on beryllium, cadmium, mercury and exposures in the glass manufacturing industry. , 1993, Scandinavian journal of work, environment & health.

[145]  P. Roberson,et al.  Endocrine mechanisms underlying the growth effects of developmental lead exposure in the rat. , 1998, Journal of toxicology and environmental health. Part A.

[146]  F. Morel,et al.  A biological function for cadmium in marine diatoms. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[147]  A. Eynard,et al.  Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[148]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[149]  W. Tang,et al.  Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteine. , 1999, Toxicology letters.

[150]  G. Goldstein,et al.  Molecular Mechanisms of Lead Neurotoxicity , 1999, Neurochemical Research.

[151]  J. Clifton Mercury exposure and public health. , 2007, Pediatric clinics of North America.

[152]  M. Ruthardt,et al.  Acute promyelocytic leukemia: PML/RARα and the leukemic stem cell , 2004, Leukemia.

[153]  M. Kondoh,et al.  Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. , 2002, The Tohoku journal of experimental medicine.

[154]  T. Lakka,et al.  Fish Oil–Derived Fatty Acids, Docosahexaenoic Acid and Docosapentaenoic Acid, and the Risk of Acute Coronary Events: The Kuopio Ischaemic Heart Disease Risk Factor Study , 2000, Circulation.

[155]  A. Favier,et al.  Trace Elements in Man and Animals 10 , 2000 .

[156]  T. Norseth Metal Carcinogenesis , 1988, Annals of the New York Academy of Sciences.

[157]  Josep M. Guerrero,et al.  Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation , 1997, FEBS letters.

[158]  T. Clarkson,et al.  Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate. , 1988, The Journal of pharmacology and experimental therapeutics.

[159]  H. Aposhian,et al.  Arsenic toxicology: five questions. , 2006, Chemical research in toxicology.

[160]  D. Townsend,et al.  A novel role for human sulfiredoxin in the reversal of glutathionylation. , 2006, Cancer research.

[161]  E. Casalino,et al.  Enzyme activity alteration by cadmium administration to rats: the possibility of iron involvement in lipid peroxidation. , 1997, Archives of biochemistry and biophysics.

[162]  S. Flora,et al.  Environmental occurrence, health effects and management of lead poisoning , 2006 .

[163]  Rudolfs K. Zalups,et al.  Molecular interactions with mercury in the kidney. , 2000, Pharmacological reviews.

[164]  Roger L. Black,et al.  Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1991 .

[165]  L. E. Rogers,et al.  Erythrocyte enzymes in experimental lead poisoning , 2004, Archiv für Toxikologie.

[166]  Beverley Hale,et al.  Molecular and cellular mechanisms of cadmium carcinogenesis. , 2003, Toxicology.

[167]  G. Lockitch Blood lead levels in children. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[168]  A. Newton Protein Kinase C: Seeing two domains , 1995, Current Biology.

[169]  J. Risher,et al.  Mercury exposure: evaluation and intervention the inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning. , 2005, Neurotoxicology.

[170]  Richa Gupta,et al.  Prevention of arsenic-induced hepatic apoptosis by concomitant administration of garlic extracts in mice. , 2009, Chemico-biological interactions.

[171]  E. Weiler,et al.  Lead-induced hypertension: possible role of endothelial factors. , 1993, American journal of hypertension.

[172]  M. Méndez-Armenta,et al.  Cadmium, Lead, Thallium: Occurrence, Neurotoxicity and Histopathological Changes of the Nervous System , 2013 .

[173]  G. El-Sokkary,et al.  Melatonin protects against lead-induced hepatic and renal toxicity in male rats. , 2005, Toxicology.

[174]  Pratibha Gautam,et al.  Response of lead-induced oxidative stress and alterations in biogenic amines in different rat brain regions to combined administration of DMSA and MiADMSA. , 2007, Chemico-biological interactions.

[175]  C. Nelson,et al.  Response Inhibition and Error Monitoring during a Visual Go/No-Go Task in Inuit Children Exposed to Lead, Polychlorinated Biphenyls, and Methylmercury , 2011, Environmental health perspectives.

[176]  J. Barrett,et al.  Induction of gene amplification by arsenic. , 1988, Science.

[177]  T. Kosatsky,et al.  Blood lead levels in children. , 1992, Canadian journal of public health = Revue canadienne de sante publique.

[178]  E. Bechara,et al.  A Free Radical Hypothesis of Lead Poisoning and Inborn Porphyrias Associated with 5-Aminolevulinic Acid Overload , 1993 .

[179]  T. H. Lin,et al.  Lead-catalyzed peroxidation of essential unsaturated fatty acid , 1995, Biological Trace Element Research.